Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > CLAS enrolling now
View:
Post by Red~One on Apr 14, 2022 8:01pm

CLAS enrolling now

CLAS is pleased to announce that it is currently enrolling a new team of paid pumpers going forward to replace the last dismal failures and duplications. The new hires will be expected to have an exaggerated sense of importance, preoccupation of unlimited success, power, brilliance, beauty, or ideal love, need for excessive admiration,
sense of entitlement, exploitative behaviour, demonstration of arrogant and haughty behaviours and/or attitudes, the belief they are special and unique and can only be understood by, or should associate with, other special or high-status people or institutions
Need for excessive admiration is preferred.

Andy Salzman said "We are very excited since this is all part of our new initiatives going forward".
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities